Skip to main content
Skip to footer
Contact Us
We are taking you to another website now.
Merck Transforms Its Regulatory Operations
Chris Lee, VP, Global Regulatory Affairs and Quality Management, Merck, explains how TCS, through ADD Regulatory, is creating solutions beneficial not only to Merck, but to the overall industry in terms of accelerating the roll-out of new drugs.
Play Video
Error: unable to play the video
volume button Opens full screen
Merck Sharpe & Dohme Corp
Life Sciences and Healthcare
Automation & AI Internet of Things Cloud, Microservices & API

TCS has collaborated and partnered with Merck to drive innovation within the pharma enterprise and streamline its business processes using digital applications and solutions.

An Innovation Council comprising experts from Merck and the TCS ADD platform launched many industry-first initiatives such as the creation of a unique, smart mobile app and executive dashboard that provides end-to-end visibility for any product’s regulatory submission. For Merck, the app and dashboard reduced the time taken to respond to regulatory queries, increased operational efficiency, sped up drug development to market, and helped plan subsequent activities in a time-bound manner.

Merck and TCS envisage bringing in joint solutions in the marketplace, leveraging core industrial strength, technology and subject matter expertise, and creating solutions that not only benefit Merck, but also achieve increased global pharma adoption and usage.

More Like This

Thank you for downloading

Your opinion counts! Let us know what you think by choosing one option below.